Impact Of Eculizumab On Hospitalization Rates And Relapse Treatment In Patients With AQP4NMOSD: The Phase 3 PREVENT Study

KİM H. J., PİTTOCK S. J., BERTHELE A., FUJİHARA K., LEVY M., PALACE J., ...Daha Fazla

Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS) Forum, 27 - 29 Şubat 2020

  • Yayın Türü: Bildiri / Özet Bildiri
  • Ondokuz Mayıs Üniversitesi Adresli: Evet